Volitionrx (VNRX) Net Income Growth (5y) (2018 - 2025)
Volitionrx (VNRX) Net Income Growth (5y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.61 Bn | 175.32 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn |
| 3 | Medtronic | 108.22 Bn | 99.00 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.29 Bn | 66.84 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.30 Bn | 44.63 Bn | 1.29 Bn |
| 6 | Dexcom | 28.31 Bn | 27.19 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.03 Bn | 25.75 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 24.04 Bn | 20.91 Bn | 2.07 Bn |
| 10 | Volitionrx | 90,551.12 | -1.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 61.41% |
| Sep 30, 2025 | -42.64% |
| Jun 30, 2025 | 39.01% |
| Mar 31, 2025 | -0.47% |
| Dec 31, 2024 | 16.43% |
| Sep 30, 2024 | 59.36% |
| Jun 30, 2024 | 15.07% |
| Mar 31, 2024 | -16.60% |
| Dec 31, 2023 | -16.67% |
| Sep 30, 2023 | -15.49% |
| Jun 30, 2023 | -17.08% |
| Jun 30, 2018 | -31.65% |